Skip to main content
. 2013 Oct 12;142(1):69–80. doi: 10.1007/s10549-013-2691-y

Fig. 2.

Fig. 2

a Disease-free survival. b Overall survival. FEC: fluorouracil/epirubicin/cyclophosphamide; T: docetaxel alone; TX: docetaxel plus capecitabine